ScholarGate
アシスタント

手法を比較

選択した手法を並べて確認できます。異なる行はハイライト表示されます。

ファーマコビジランスにおけるPRR/ROR×Caco-2細胞透過性アッセイ×集団薬物動態モデル(Population Pharmacodynamic Modeling)×
分野薬理学薬理学薬理学
系統Process / pipelineProcess / pipelineProcess / pipeline
提唱年200219891992
提唱者Arne Melander and colleaguesIngrid HidalgoLewis Sheiner and Stephen Roush
種類safety signal detectionabsorption screeningdose-response modeling
原典Szarfman, A., Tonning, J. M., Doraiswamy, P. M., & Osgood, D. J. (2002). Pharmacovigilance in the post-marketing setting: establishing causal links between drugs and adverse events. Drug Safety, 25(9), 619-631. link ↗Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736-749. DOI ↗Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗
別名PRR, ROR, signal detection, adverse event monitoringCaco-2 assay, intestinal permeability, ADME screeningPopPD, population PD, hierarchical PD modeling
関連333
概要Proportional Reporting Ratio (PRR) and Reporting Odds Ratio (ROR) are statistical methods for detecting safety signals in spontaneous adverse event reporting databases. Developed and formalized by researchers in the early 2000s, these measures identify drug-adverse event associations that warrant further investigation.The Caco-2 assay is an in vitro model system using human colon carcinoma cell monolayers to screen drug intestinal permeability. Developed by Hidalgo and colleagues in 1989, Caco-2 cells differentiate into an epithelial barrier resembling intestinal mucosa, enabling rapid assessment of drug absorption potential and identification of transporter-mediated transport.Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction.
ScholarGateデータセット
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 2 出典
  3. PUBLISHED
  1. v1
  2. 2 出典
  3. PUBLISHED

検索へ スライドをダウンロード

ScholarGate手法を比較: Pharmacovigilance PRR/ROR · Caco-2 Permeability · Population Pharmacodynamics. 2026-06-20に以下より取得 https://scholargate.app/ja/compare